Cited 0 times in 
Cited 2 times in 
Preclinical activity of NVL-655 in patient-derived models of ALK cancers, including those with lorlatinib-resistant G1202R/L1196M compound mutation
https://orcid.org/0000-0002-5562-270XItems in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.